APLT — Applied Therapeutics Balance Sheet
0.000.00%
Last trade - 00:00
- $488.95m
- $438.80m
- $9.99m
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 38.9 | 96.8 | 80.8 | 30.6 | 50.2 |
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 46.2 | 103 | 88.4 | 37.3 | 54.4 |
Net Property, Plant And Equipment | 2.04 | 1.71 | 1.3 | 0.857 | 0.447 |
Other Long Term Assets | |||||
Total Assets | 48.4 | 105 | 89.9 | 38.4 | 54.8 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 14.1 | 21.2 | 26.5 | 33.4 | 71.2 |
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 15.8 | 22.6 | 27.4 | 34.3 | 72 |
Non Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 32.6 | 81.9 | 62.5 | 4.06 | -17.1 |
Total Liabilities & Shareholders' Equity | 48.4 | 105 | 89.9 | 38.4 | 54.8 |
Total Common Shares Outstanding |